Am J Transplant . Reconciling short-term clinical and Immunological outcomes of SARS-CoV-2 vaccination in Solid Organ Transplant recipients

[tetano]

Am J Transplant


. 2021 Sep 23.
doi: 10.1111/ajt.16855. Online ahead of print.
Reconciling short-term clinical and Immunological outcomes of SARS-CoV-2 vaccination in Solid Organ Transplant recipients


Oriol Bestard ^{1 2} , Thomas Jouve ² , Lluís Castells ^{3 4} , Manuel Lopez ⁵ , Marina Muñoz ⁶ , Elena Crespo ² , Nestor Toapanta ¹ , Juliana Esperalba ⁷ , Isabel Campos-Varela ^{3 4} , Teresa Pont ⁷ , Oscar Len ⁷ , Magda Campins ⁸ , Francesc Moreso ^{1 2}



Affiliations

• PMID: 34554648
• DOI: 10.1111/ajt.16855

Abstract

Relevant concerns are being raised regarding the weak serological response of solid organ transplant (SOT) recipients after receiving two doses of messenger RNA-based vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1) and some severe cases of coronavirus disease (COVID-19) occurring after vaccination (2). Thus, additional preventive booster doses are proposed to enhance anti-viral immunity.